Literature DB >> 15298465

Factors associated with tumour stage at presentation in invasive cervical cancer.

N Ndlovu1, R Kambarami.   

Abstract

OBJECTIVE: The main objective of the study was to determine the demographic, social, clinical, laboratory and histologic factors associated with late stage presentation in cervical cancer.
DESIGN: A cross sectional study.
SETTING: Government tertiary referral institutions, Harare, Zimbabwe STUDY POPULATION: One hundred consecutive cases of histology proven cervical cancer that presented for treatment between November 2001 and April 2002. MAIN OUTCOME MEASURES: The patients were categorized as early invasive cancer (stage I and II) and late invasive cancer (stage III and IV).
RESULTS: The median age of the patients was 48 years (Q1=39 and Q3= 60). Eighty percent presented with late stage disease. Squamous cell carcinoma was the commonest histology (96%) with adenocarcinoma constituting only 4% of all tumours. Poorly differentiated tumour histology and no history of prior cervical cancer screening were found to be significantly associated with late tumour stage at presentation. The odds of presenting with late stage disease in women with a poorly differentiated tumour were 12.97 (95% CI 2.03 to 82.55; p = .007), whilst the odds of late stage presentation in the absence of a history of screening were 11.13 (95% CI 1.33 to 93.21; p = .026).
CONCLUSIONS: Intrinsic tumour characteristics were the most important in this population in determining late stage at diagnosis and the value of screening was also highlighted by the results. The odds ratios had wide 95% confidence intervals, thus limiting their usefulness as point estimates.

Entities:  

Mesh:

Year:  2003        PMID: 15298465

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  17 in total

1.  Will HPV vaccination affect cervical cancer morbidity and mortality world-wide?

Authors:  Rebecca Luckett; Sarah Feldman
Journal:  Hum Vaccin Immunother       Date:  2016-06-02       Impact factor: 3.452

2.  Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium.

Authors:  Mark H Einstein; Ntokozo Ndlovu; Jeannette Lee; Elizabeth A Stier; Jeffrey Kotzen; Madhur Garg; Kathleen Whitney; Shelly Y Lensing; Mariza Tunmer; Webster Kadzatsa; Joel Palefsky; Susan E Krown
Journal:  Gynecol Oncol       Date:  2019-02-15       Impact factor: 5.482

Review 3.  Optimal management of cervical cancer in HIV-positive patients: a systematic review.

Authors:  Atara Ntekim; Oladapo Campbell; Dietrich Rothenbacher
Journal:  Cancer Med       Date:  2015-07-01       Impact factor: 4.452

4.  Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya.

Authors:  Innocent O Maranga; Lynne Hampson; Anthony W Oliver; Anas Gamal; Peter Gichangi; Anselmy Opiyo; Catharine M Holland; Ian N Hampson
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

5.  Understanding cervical cancer: an exploration of lay perceptions, beliefs and knowledge about cervical cancer among the Acholi in northern Uganda.

Authors:  Amos Deogratius Mwaka; Elialilia Sarikiaeli Okello; Juliet Kiguli; Elizeus Rutebemberwa
Journal:  BMC Womens Health       Date:  2014-07-15       Impact factor: 2.809

6.  Symptomatic presentation with cervical cancer in Uganda: a qualitative study assessing the pathways to diagnosis in a low-income country.

Authors:  Amos Deogratius Mwaka; Elialilia Sarikiaeli Okello; Henry Wabinga; Fiona M Walter
Journal:  BMC Womens Health       Date:  2015-02-18       Impact factor: 2.809

7.  Human immunodeficiency virus seroprevalence in patients with invasive cervical cancer in Zaria, North-Western Nigeria.

Authors:  Adamu Abdullahi; Muhammad Inuwa Mustapha; Dawotola Ayorinde David; Olasinde Tajudeen Ayodeji
Journal:  Ann Afr Med       Date:  2018 Jan-Mar

Review 8.  Barriers and Challenges to Treatment Alternatives for Early-Stage Cervical Cancer in Lower-Resource Settings.

Authors:  Emily S Wu; Jose Jeronimo; Sarah Feldman
Journal:  J Glob Oncol       Date:  2017-05-11

9.  Cervical cancer in Zimbabwe: a situation analysis.

Authors:  Oppah Kuguyo; Alice Matimba; Nomsa Tsikai; Thulani Magwali; Mugove Madziyire; Muchabayiwa Gidiri; Collet Dandara; Charles Nhachi
Journal:  Pan Afr Med J       Date:  2017-07-21

10.  Assessing Factors Associated With Survival Among Cervical Cancer Patients in Kenya: A Retrospective Follow-up Study.

Authors:  Damar Osok; Simon Karanja; Yeri Kombe; Eliud Njuguna; Jim Todd
Journal:  East Afr Health Res J       Date:  2018-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.